Skip to main content
. 2012 Sep 28;4(6):1010–1016. doi: 10.3892/etm.2012.730

Figure 3.

Figure 3

Progression-free (PFS) survival according to different genotypes. (A) Patients with 2R allele and 3R allele shared similar PFS (112 vs. 122 days, p=0.518). (B) No significant difference was observed between patients with ins6/del6 and del6/del6 polymorphisms and those with ins6/ins6 (112 vs. 147 days, p=0.776). (C) Combination of different genotypes did not yield significant differences (86 vs. 147 vs. 126 days, p=0.938).